- Home
- APLT vs CLPR Comparison
APLT vs CLPR Comparison
Compare APLT & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- CLPR
- Stock Information
- Founded
- APLT 2016
- CLPR 2015
- Country
- APLT United States
- CLPR United States
- Employees
- APLT N/A
- CLPR N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- APLT Health Care
- CLPR Real Estate
- Exchange
- APLT Nasdaq
- CLPR Nasdaq
- Market Cap
- APLT 37.5M
- CLPR 57.8M
- IPO Year
- APLT 2019
- CLPR 2017
- Fundamental
- Price
- APLT $0.41
- CLPR $4.07
- Analyst Decision
- APLT Buy
- CLPR
- Analyst Count
- APLT 7
- CLPR 0
- Target Price
- APLT $6.10
- CLPR N/A
- AVG Volume (30 Days)
- APLT 1.9M
- CLPR 87.5K
- Earning Date
- APLT 05-20-2025
- CLPR 05-20-2025
- Dividend Yield
- APLT N/A
- CLPR 9.36%
- EPS Growth
- APLT N/A
- CLPR N/A
- EPS
- APLT N/A
- CLPR N/A
- Revenue
- APLT $455,000.00
- CLPR $148,775,000.00
- Revenue This Year
- APLT $1,768.13
- CLPR N/A
- Revenue Next Year
- APLT $361.28
- CLPR N/A
- P/E Ratio
- APLT N/A
- CLPR N/A
- Revenue Growth
- APLT N/A
- CLPR 7.65
- 52 Week Low
- APLT $0.30
- CLPR $3.38
- 52 Week High
- APLT $10.62
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- APLT 48.67
- CLPR 62.22
- Support Level
- APLT $0.39
- CLPR $3.70
- Resistance Level
- APLT $0.49
- CLPR $4.09
- Average True Range (ATR)
- APLT 0.04
- CLPR 0.18
- MACD
- APLT 0.01
- CLPR 0.07
- Stochastic Oscillator
- APLT 55.40
- CLPR 96.25
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.